Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMustang Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Mustang Bio, Inc. Earnings Date And Information
Mustang Bio, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-2 earnings per share for the quarter, topping analysts' consensus estimates of $-6.5 by $4.5. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Mustang Bio, Inc. has generated $-6 earnings per share over the last year ($-6 diluted earnings per share) and currently has a price-to-earnings ratio of -2.2. Mustang Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Mustang Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$6.50 | -$0.04 | 6.46 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$7.00 | -$1.10 | 5.9 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$0.87 | -$0.46 | 0.41 | N/A | $0 |
| 03/11/2024 | Q4 2023 | -$84.00 | -$0.93 | 83.07 | N/A | $2.88 M |
| 11/14/2023 | Q3 2023 | -$94.00 | -$1.23 | 92.77 | $3.00 M | $0 |
| 08/14/2023 | Q2 2023 | -$103.50 | -$2.00 | 101.5 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$142.50 | -$2.25 | 140.25 | N/A | $0 |
| 03/29/2023 | Q4 2022 | N/A | -$2.91 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$149.93 | -$2.42 | 147.51 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$157.42 | -$2.50 | 154.92 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$134.93 | -$3.06 | 131.87 | N/A | $0 |
| 03/23/2022 | Q4 2021 | -$157.42 | -$3.42 | 154 | N/A | $0 |
| 11/12/2021 | Q3 2021 | -$134.93 | -$2.80 | 132.13 | N/A | $0 |
| 08/16/2021 | Q2 2021 | -$149.93 | -$2.46 | 147.47 | N/A | $0 |
| 05/14/2021 | Q1 2021 | -$149.93 | -$2.79 | 147.14 | N/A | $0 |
| 03/24/2021 | Q4 2020 | -$157.42 | -$5.88 | 151.54 | N/A | $0 |
| 11/06/2020 | Q3 2020 | -$194.90 | -$3.39 | 191.51 | N/A | $0 |
| 08/10/2020 | Q2 2020 | -$209.90 | -$4.86 | 205.04 | N/A | $0 |
| 05/11/2020 | Q1 2020 | -$254.87 | -$4.24 | 250.63 | N/A | $0 |
| 03/16/2020 | Q4 2019 | -$187.41 | -$6.74 | 180.67 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mustang Bio, Inc. Earnings: FAQ's
Mustang Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based offlast year's report dates.
In the previous quarter, Mustang Bio, Inc. (:MBIO) reported $-2 earnings per share (EPS) to beat the analysts' consensus estimate of $-6.5 by $4.5.
The conference call for Mustang Bio, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Mustang Bio, Inc.'s latest earnings report can be read online.
Mustang Bio, Inc. (:MBIO) has a recorded net income of $-51,602,000.Mustang Bio, Inc. has generated $-6 earnings per share over the last four quarters.
Mustang Bio, Inc. (:MBIO) has a price-to-earnings ratio of -2.2 and price/earnings-to-growth ratio is -0.07.